{
    "nctId": "NCT02595762",
    "briefTitle": "A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer",
    "officialTitle": "A Disease Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer, Locally Advanced Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 110,
    "primaryOutcomeMeasure": "Percentage of Participants Receiving Each Unique Treatment Regimen Overall",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of HER2-positive unresectable LABC or MBC within 6 months prior to enrollment\n\nExclusion Criteria:\n\n* None specified",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}